Abstract |
As studies indicate that genomic and nongenomic pathways are involved in mediating the salutary effects of 17beta-estradiol (E2) following trauma- hemorrhage, we examined if the nongenomic effects of E2 on attenuation of intestinal injury after trauma- hemorrhage involve the PI-3K/Akt pathway. Male Sprague-Dawley rats ( approximately 300 g body weight) underwent trauma- hemorrhage (mean blood pressure 40 mmHg for 90 min), followed by resuscitation. E2 conjugated to BSA (E2-BSA; 1 mg/Kg E2), with or without an estrogen receptor antagonist ( ICI 182,780), a PI-3K inhibitor ( Wortmannin), or vehicle, was injected i.v. during resuscitation. At 2 h after trauma- hemorrhage or sham operation, intestinal myeloperoxidase (MPO) activity, ICAM-1, cytokine-induced neutrophil chemoattractant (CINC)-1, CINC-3, and IL-6 levels were measured (n=6 rats/group). Intestinal PI-3K, phosphorylation of Akt (p-Akt), and Akt protein expressions were also determined. One-way ANOVA and Tukey's test were used for statistical analysis. The results indicated that trauma- hemorrhage increased intestinal MPO activity and ICAM-1, CINC-1, CINC-3, and IL-6 levels. These parameters were improved significantly in the E2- or E2-BSA-treated rats subjected to trauma- hemorrhage. Although trauma- hemorrhage decreased intestinal PI-3K and p-Akt protein expressions, E2 or E2-BSA treatment following trauma- hemorrhage prevented such decreases in intestinal PI-3K and p-Akt protein expressions. Coadministration of ICI 182,780 or Wortmannin abolished the beneficial effects of E2-BSA on attenuation of intestinal injury following trauma- hemorrhage. Thus, the PI-3K/Akt pathway plays a critical role in mediating the nongenomic, salutary effects of E2 on attenuation of shock-induced intestinal tissue damage.
|
Authors | Huang-Ping Yu, Ya-Ching Hsieh, Takao Suzuki, Mashkoor A Choudhry, Martin G Schwacha, Kirby I Bland, Irshad H Chaudry |
Journal | Journal of leukocyte biology
(J Leukoc Biol)
Vol. 82
Issue 3
Pg. 774-80
(Sep 2007)
ISSN: 0741-5400 [Print] United States |
PMID | 17586659
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Androstadienes
- Chemokine CXCL1
- Chemokines, CXC
- Cxcl1 protein, rat
- Estrogen Antagonists
- Estrogen Receptor Modulators
- Interleukin-6
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors
- Receptors, Estrogen
- Intercellular Adhesion Molecule-1
- Fulvestrant
- Estradiol
- Peroxidase
- Proto-Oncogene Proteins c-akt
- Wortmannin
|
Topics |
- Androstadienes
(pharmacology)
- Animals
- Blotting, Western
- Chemokine CXCL1
- Chemokines, CXC
(metabolism)
- Estradiol
(analogs & derivatives, pharmacology)
- Estrogen Antagonists
(pharmacology)
- Estrogen Receptor Modulators
(pharmacology)
- Fulvestrant
- Genome
- Intercellular Adhesion Molecule-1
(metabolism)
- Interleukin-6
(metabolism)
- Intestine, Small
(drug effects, enzymology)
- Male
- Peroxidase
(metabolism)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation
- Protein Kinase Inhibitors
(pharmacology)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Rats
- Rats, Sprague-Dawley
- Receptors, Estrogen
(antagonists & inhibitors, metabolism)
- Shock, Hemorrhagic
(drug therapy, metabolism)
- Up-Regulation
- Wortmannin
- Wounds and Injuries
(drug therapy, metabolism)
|